Treatment of idiopathic pulmonary fibrosis (IPF) rats with adenoviral delivery of the vascular endothelial growth factor (VEGF) gene resulted in reduced endothelial apoptosis, increased vascularization, and improved PAP due to reduced remodeling but worsened PF [46]. The gene discussed is VEGFA; the disease is idiopathic pulmonary fibrosis.